Global Preventive Asthma Drugs Market 2015-2019

PART 01: Executive summary 
Highlights  
PART 02: Scope of  the report 
Market overview  
Top-vendor offerings  
PART 03: Market research methodology 
Research methodology  
Economic indicators  
PART 04: Introduction 
Key market highlights  
PART 05: Product Profiles 
Accolate  
Pulmicort  
Symbicort  
Xolair  
Advair  
Anoro Ellipta  
Arnuity Ellipta  
Breo Ellipta  
Flovent  
Serevent  
Ventolin  
Asmanex  
Foradil  
Dulera  
Singulair  
PART 06: Disease Overview 
Understanding the disease  
Symptoms  
Pathophysiology  
Epidemiology  
Diagnosis  
Management  
PART 07: Pipeline Portfolio 
PART 08: Market landscape 
Market overview  
Market size and forecast  
Five forces analysis  
PART 09: Market segmentation by class of drugs 
PART 10: LABA/ICS combination 
Global LABA/ICS combination market  
PART 11: Immunosuppressants 
Global immunosuppressants market  
PART 12:   Leukotriene Antagonists  
Global leukotriene antagonists market  
PART 13: Mast Cell Stabilizers 
Mast cell stabilizers market  
PART 14: Inhaled corticosteroids 
Global corticosteroids market  
PART 15: Geographical segmentation 
Global preventive asthma drugs market by geographical segmentation 2014-2019  
Preventive asthma drugs market in Americas  
Preventive asthma drugs market in EMEA  
Preventive asthma drugs market in APAC  
PART 16: Market drivers 
PART 17: Impact of drivers 
PART 18: Market challenges 
PART 19: Impact of drivers and challenges 
PART 20: Market trends 
PART 21: Vendor landscape 
Competitive Scenario  
Market Share Analysis 2014  
Other and future prominent vendors  
PART 22: Key vendor analysis 
AstraZeneca  
F. Hoffmann-La Roche  
GlaxoSmithKline  
Merck & Co  
Novartis  
List of abbreviation